ArticleBiochemistry and biophysics reports2026
Integrated single-cell transcriptomic analysis identifies
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Megakaryocytes (MKs) and low-density granulocytes (LDGs) are implicated in immune dysregulation and vascular pathology in autoimmune diseases (ADs), yet their precise subsets and pathological interactions remain poorly defined. We aimed to characterize MK and LDG subpopulations and elucidate their potential intercellular communication in ADs using single-cell transcriptomic analysis. Methods: Single-cell RNA sequencing (scRNA-seq) was performed on peripheral blood mononuclear cells from 10 treatment-naive AD patients (4 pSS, 3 RA, and 3 SLE) and 3 healthy controls (HCs). MKs and LDGs were re-clustered to identify transcriptional subpopulations and interrogated for intercellular communication using CellChat. A distinct megakaryocyte-like granulocyte population was validated in an independent scRNA-seq dataset. Bulk RNA-seq (n = 139) and plasma ELISA assays were employed to support the associated molecular signatures. Crucially, flow cytometry of peripheral blood from AD patients (n = 5) and HCs (n = 4) was performed to provide protein-level validation of the identified megakaryocyte-like granulocytes. Results: MKs segregated into immune-active and platelet-generating subtypes, both exhibiting altered signaling in ADs. LDGs harbored a unique Conclusions: We identify a potentially
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.